SCN1A mutations are associated with various forms of seizures and epilepsies on a wide spectrum of severity, including “isolated” febrile seizures as well as Dravet syndrome (DS), a developmental and epileptic encephalopathy of poor prognosis. Here, SCN1A is linked to epilepsy.